技术文章

血管紧张素1转换酶抑制剂抗体来源;ACEI抗体条件

上海道壹生物科技有限公司

2016/12/13 10:26:16

血管紧张素1转换酶抑制剂抗体;ACEI
ACEI(Angiotensin I Converting Enzyme Inhibitor; Bradykinin-potentiating peptide)(血管紧张素转换酶抑制剂)可以温和、持久地降压,同时对靶器官有很好的保护作用。
ACEI主要作用于RAS(肾素-血管紧张素系统),通过抑制RAS中的血管紧张素转换酶(ACE)而减少血管紧张素II(Ang II)的生成,从而发挥控制血压,保护靶器官的作用。同时他还能调节交感神经系统活性,增加前列腺素合成。
抗体来源:兔子
克隆类型:多克隆抗体
交叉反应:人、大鼠、小鼠、兔、猪、马、牛
抗体应用:ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复) 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量:9.5kDa
性状:Lyophilized or Liquid
浓度:1mg/1ml
免疫原:KLH conjugated synthetic peptide of ACEI (C-PTHIKWGD)
亚型:IgG
纯化方法:affinity purified by Protein A
储存液:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
抗体条件:Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
background:
Angiotensin I converting Enzyme Inhibitor, ACEI also designated Bradykinin-potentiating peptide. The peptide: PTHIKWGD. Processed active peptide.
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 
抗体供应商:上海华壹生物科技有限公司
Shanghai HuaYi Bio-technology Co.,Ltd

相关产品

当前客户在线交流已关闭
请电话联系他 :